You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

Details for Patent: 11,351,122

✉ Email this page to a colleague

« Back to Dashboard

Which drugs does patent 11,351,122 protect, and when does it expire?

Patent 11,351,122 protects DROSPIRENONE and SLYND and is included in two NDAs.

This patent has sixty-five patent family members in twenty-nine countries.

Summary for Patent: 11,351,122

Title:	Synthetic progestogens and pharmaceutical compositions comprising the same
Abstract:	Described herein are synthetic progestogens, such as 6.beta.,7.beta.:15.beta.,16.beta.-Dimethylene-3-oxo-17.alpha.-pregn-4-ene- -21,17-carbolactone, as well as pharmaceutical compositions comprising the same. Also described are methods of use.
Inventor(s):	Perrin; Philippe (Paris, FR), Velada; Jose Luis (Amersfoort, NL), Drouin; Dominique (Verrieres-le-Buisson, FR)
Assignee:	LABORATORIOS LEON FARMA SA (Leon, ES)
Application Number:	17/684,261
Patent Claim Types: see list of patent claims	Composition; Formulation; Compound; Dosage form;

Drugs Protected by US Patent 11,351,122

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Exeltis Usa Inc	DROSPIRENONE	drospirenone	TABLET, CHEWABLE;ORAL	216285-001	Jun 29, 2022		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up	Y				⤷ Sign Up
Exeltis Usa Inc	SLYND	drospirenone	TABLET;ORAL	211367-001	May 23, 2019	AB	RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up	Y				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

International Family Members for US Patent 11,351,122

Subscribe to access the full database, or Sign Up
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
European Patent Office	2588114	⤷ Sign Up	CA 2020 00023	Denmark	⤷ Sign Up
European Patent Office	2588114	⤷ Sign Up	2020C/518	Belgium	⤷ Sign Up
European Patent Office	2588114	⤷ Sign Up	19/2020	Austria	⤷ Sign Up
European Patent Office	2588114	⤷ Sign Up	C202030026	Spain	⤷ Sign Up
European Patent Office	2588114	⤷ Sign Up	301123	Netherlands	⤷ Sign Up
European Patent Office	2588114	⤷ Sign Up	PA2021523	Lithuania	⤷ Sign Up
European Patent Office	2588114	⤷ Sign Up	LUC00227	Luxembourg	⤷ Sign Up
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.